Pankhurst, C. L. (2012). Candidiasis (oropharyngeal). BMJ Clinical Evidence, 2012 . Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429411/ Pearlman, B. A. (1974). An oral contraceptive drug and gingival enlargement: The relationship between local and systemic factors. Journal of Clinical Periodontology, 1 (1), 47-51. Pereira, L. J., & van der Bilt, A. (2016). The influence of oral processing, food perception and social aspects on food consumption: A review. Journal of Oral Rehabilitation 43 (8), 630-648. doi:10.1111/joor.12395 Perlin, D. S. (2015). Echinocandin resistance in Candida. Clinical Infectious Diseases, 61 (Suppl. 6), S612-617. Pfizer Canada Inc. (2014). Product monograph: PrSalagen ® . Retrieved from http://www. pfizer.ca/sites/g/files/g10023216/f/201505/SALAGEN_PM_E_25Sept2014_175412.pdf Pienaar, E. D., Young, T., & Holmes, H. (2010). Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children. Cochrane Database of Systematic Reviews, 2010 (11), CD003940. doi:10.1002/14651858.CD003940.pub3. Pietkiewicz, P., Gornowicz-Porowska, J., Bowszyc-Dmochowska, M., & Dmochowski, M. (2015). A retrospective study of antihypertensives in pemphigus: A still unchartered odyssey particularly between thiols, amides and phenols. Archives of Medical Science, 11 (5), 1021- 1027. Pinto, A. (2014). Management of xerostomia and other complications of Sjogren’s syndrome. Oral & Maxillofacial Surgical Clinics of North America, 26 (1), 63-73. Probst, F. A., Probst, M., & Bisdas, S. (2015). Imagining modalities and characteristics in medication-related osteonecrosis of the jaw. In S. Otto (Ed.), Medication-related osteonecrosis of the jaws (pp. 63-78). New York, NY: Springer. Proc, P., Szczepanska, J., Skiba, A., Zubowska, M., Fendler, W., & Mlynarski, W. (2016). Dental anomalies as late adverse effect among young children treated for cancer. Cancer Research and Treatment, 48 (2), 658-667. Proctor, G. B. (2016). The physiology of salivary secretion. Periodontology 2000 , 70(1), 11-25. Radulescu, M. (2016). The pharmacologic management of common lesions of the oral cavity. Dental Clinics of North America, 60 (2), 407-420. doi:10.1016/j.cden.2015.12.003. Raizada, S., Varghese, J. M., Bhat, K. M., & Gupta, K. (2016). Isolated gingival overgrowths: A review of case series. Contemporary Clinical Dentistry, 7 (2), 265-268. Riley, P., Glenny, A. M., Worthington, H. V., Littlewood, A., Fernandez Mauleffinch, L. M., Clarkson, J. E., & McCabe, M. G. (2017). Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors. Cochrane Database of Systematic Reviews, 11: CD011990. doi: 10.1002/14651858.CD011990.pub2. Riley, T. T., Muzny, C. A., Swiatlo, E., & Legendre, D. P. (2016). Breaking the mold: A review of mucormycosis and current pharmacological treatment options. Annals of Pharmacotherapy, 50 (9), 747-757. Rosebush, M. S., Briody, A. N., & Cordell, K. G. (2019). Black and Brown: Non-neoplastic Pigmentation of the Oral Mucosa. Head and Neck Pathology,13 (1):47-55. Rostami, A. M., & Brooks, J. K. (2011). Intraoral chemical burn from use of 3% hydrogen peroxide. General Dentistry, 59 (6), 504-506. Ruggiero, S. L., Dodson, T. B., Fantasia, J., Goodday, R., Aghaloo, T., Mehrotra, B., & O’Ryan, F. (2014). American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw – 2014 update. Journal of Oral and Maxillofacial Surgery, 72 (10), 1938-1956. doi:10.1016/j.joms.2014.04.031. Sarda, T. S., & Rathod, S. R. (2015). Drug induced gingival enlargement – A menace to the gingiva: Case report . Journal of Oral Health Research, 6 (2), 5-10. Sanchez, A. R., Rogers, R. S., 3rd, & Sheridan, P. J. (2004). Tetracycline and other tetracycline- derivative staining of the teeth and oral cavity. International Journal of Dermatology, 43 (10), 709-715. Scully, C. (Ed.). (2008). Oral and maxillofacial medicine: The basis of diagnosis and treatment. London, UK: Churchill Livingstone/Elsevier. Seymour, R. A., & Rudralingham, M. (2008). Oral and dental adverse drug reactions. Periodontology 2000, 46, 9-26. Sharma, V., Somasundara, S. Y., Prasanna Kumar, Y. S., & Bhat, P. K. (2014). Is assessment of hyposalivation important in routine dental practice? Journal of Health Sciences & Research, 5 (2), 10-14. Sillanpaa, S., Sipila, M., Numminen, J., & Rautiainen, M. (2015). The experience of treating drooling with repeated botulinum toxin Injections. ORL, 77(6), 333-338. Singh, M. L., & Papas, A. (2014). Oral implications of polypharmacy in the elderly. Dental Clinics of North America, 58 (4), 783-796. doi:10.1016/j.cden.2014.07.004. Sreeja, C., Ramakrishnan, K., Vijayalakshmi, D., Devi, M., Aesha, I., & Vijayabanu, B. (2015). Oral pigmentation: A review. Journal of Pharmacy and Bioallied Sciences, 7 (Suppl. 2), S403- 408. doi:10.4103/0975-7406.163471. Stavropoulos, P. G., Soura, E., & Antoniou, C. (2013). Drug-induced pemphigoid: A review of the literature. Journal of the European Academy of Dermatology and Venereology, 28 (9), 1133-1140. Sumanth, S., Bhat, K. M., & Bhat, G. S. (2007). Clinical management of an unusual case of gingival enlargement. The Journal of Contemporary Dental Practice, 8 (4), 88-94. Syed, M., Chopra, R., & Sachdev, V. (2015). Allergic reactions to dental materials – A systematic review. Journal of Clinical and Diagnostic Research, 9 (10), ZE04-09. doi:10.7860/ JCDR/2015/15640.6589. Teoh, L., Moses, G., & McCullough, M. J. (2019). A review and guide to drug-associated oral adverse effects-Dental, salivary and neurosensory reactions. Part 1. Journal of Oral Pathology & Medicine . doi: 10.1111/jop.12911. Than, T. P., & Hardie, E. B. (2012, October). Meds that don’t mix with glaucoma patients. Optometry Review. Retrieved from https://www.reviewofoptometry.com/ce/meds-that-dont- mix-with-glaucoma-patients Trackman, P. C., & Kantarci, A. (2015). Molecular and clinical aspects of drug-induced gingival overgrowth. Journal of Dental Research, 94 (4), 540-546. University of Iowa College of Dentistry and Dental Clinics. (2019). Research: Iowa Fluoride Study . Retrieved from: https://www.dentistry.uiowa.edu/preventive-fluoride-study U.S. Department of Health and Human Services Panel on Community Water Fluoridation. (2015). U.S. Public Health Service recommendation for fluoride concentration in drinking water for the prevention of dental caries. Public Health Reports, 130 (4), 318-331. van de Veerdonk, F. L., & Netea, M. G. (2016). Treatment options for chronic mucocutaneous candidiasis. Journal of Infection, 5 ;72 Suppl:S56-60. Villa, A., & Sonis, S. (2018). Oral leukoplakia remains a challenging condition. Oral Disease, 24 (1-2):179-183. Villa, A., & Sonis, S. T. (2015). Mucositis: Pathobiology and management. Current Opinion in Oncology, 27 (3), 159-164. doi:10.1097/CCO.0000000000000180. Weinstein, I., & Rosencrans, M. (1962). Treatment of black hairy tongue with triamcinolone acetonide. Report of a case. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics, 15, 1071-1074. Wolff A, Joshi R. K., Ekström J, Aframian D, Pedersen A. M., Proctor G, Narayana N, Villa A, Sia Y. W., Aliko A, McGowan R, Kerr A. R., Jensen S. B., Vissink A, Dawes C.. (2017). A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI. Drugs in R&D, 17 (1):1-28. Wormser, G. P., Wormser, R. P., Strle, F., Myers, R., & Cunha, B. A. (2019). How safe is doxycycline for young children or for pregnant or breastfeeding women?. Diagnostic microbiology and infectious disease , 93 (3), 238–242. Worsnop, F., Wee, J., Natkunarajah, J., Moosa, Y., & Marsden, R. (2012). Reaction to biological drugs: infliximab for the treatment of toxic epidermal necrolysis subsequently triggering erosive lichen planus. Clinical and Experimental Dermatology, 37 (8), 879-881. doi:10.1111/j.1365-2230.2012.04357.x. Yuan, A., & Woo, S. B. (2015). Adverse drug events in the oral cavity. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, 11 . Zoheir, N., & Hughes, F. J. (2020). The Management of Drug-Influenced Gingival Enlargement. Primary dental journal, 8 (4), 34–39. https://doi. org/10.1308/205016820828463816
Hellstein, J. W., Adler, R. A., Edwards, B., Jacobsen, P. L., Kalmar, J. R., Koka, S. … Ristic, H. (2011). Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis: Recommendations from the American Dental Association Council on Scientific Affairs. Retrieved from https://www.aae.org/uploadedfiles/publications_ and_research/endodontics_colleagues_for_excellence_newsletter/bonj_ada_report.pdf Hong, L., Levy, S. M., Warren, J. J., Broffitt, B., & Cavanaugh, J. (2006). Fluoride intake levels in relation to fluorosis development in permanent maxillary central incisors and first molars. Caries Research, 40, 494-500. Jacobsen, P. E., Henriksen, T. B., Haubek, D., & Østergaard, J. R. (2014). Prenatal exposure to antiepileptic drugs and dental agenesis. PLOS ONE, 9 (1), e84420. doi:10.1371/journal. pone.0084420. Jain, A., & Gupta, N. (2015). Multifocal bullous fixed drug eruption due to phenytoin: A lesson learned! Journal of Clinical and Diagnostic Research, 9 (12), OD04-05. Jallouli, M., Frances, C., Piette, J. C., du Huong, L. T., Moguelet, P., Factor, C. N., … Costedoat-Chalumeau, N. (2013). Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematosus: A case-control study. JAMA Dermatology, 149 (8), 935- 940. doi: 10.1001/jamadermatol.2013.709. Jordan, R. C. K., & Lewis, M. A. O. (2013). Oral medicine: A color handbook. (2nd ed.). Boca Raton, FL: CRC Press. Jost, W. H., Steffen, A., & Berweck, S. (2021). A critical review of incobotulinumtoxinA in the treatment of chronic sialorrhea in pediatric patients. Expert review of neurotherapeutics , 21 (10), 1059–1068. https://doi.org/10.1080/14737175.2021.1979959 Kalmar, J. R. (2016). Oral manifestations of drug reactions. Retrieved from http://emedicine. medscape.com/article/1080772-overview Kanjanabuch, P., Arporniem, S., Thamrat, S., & Thumasombut, P. (2012). Mucous membrane pemphigoid in a patient with hypertension treated with atenolol: A case report. Journal of Medical Case Reports, 6, e373. doi:10.1186/1752-1947-6-373. Khzam, N., Bailey, D., Yie, H. S., & Bakr, M. M. (2016). Gingival enlargement induced by felodipine resolves with a conventional periodontal treatment and drug modification. Case Reports in Dentistry, 2016, Article ID: 1095927. Kilic, E., & Doganay, O. (2018). Current management concepts for bisphosphonate-related osteonecrosis of the jaw: a review. General Dentistry, 66 (6): e1-e5. Kuhn, M., & Türp, J. C. (2018). Risk factors for bruxism. Swiss Dental Journal, 12 ;128(2): 118-124. Kumar, A., Kumar, V., Singh, J., Hooda, A., & Dutta, S. (2012). Drug-induced discoloration of teeth: An updated review. Clinical Pediatrics (Philadelphia), 51 (2), 181-185. doi:10.1177/0009922811421000. Kumarasinghe, S. P. W., Pandya, A., Chandran, V., Rodrigues, M., Dlova, N. C., Kang, H. Y., Ramam, M., Dayrit, J. F., Goh, B. K., & Parsad, D. (2019). A global consensus statement on ashy dermatosis, erythema dyschromicum perstans, lichen planus pigmentosus, idiopathic eruptive macular pigmentation, and Riehl’s melanosis. International Journal of Dermatology, 58 (3):263-272. Kuroshima, S., Sasaki, M., & Sawase, T. (2019). Medication-related Osteonecrosis of the Jaw: A Literature Review. Journal of Oral Biosciences, May 14. pii: S1349-0079(19)30047-7. doi: 10.1016/j.job.2019.03.005. Kuzenko, Y., Mykhno, O., Sikora, V., Bida, V., & Bida, O. (2022). Dental terminology "discoloration" or "pigment dystrophy" - a review and practical recommendations. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego , 50 (295), 65–67. Lalla, R. V., Bowen, J., Barasch, A., Elting, L., Epstein, J., Keefe, D. M., … Elad, S. (2014). MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer, 120 (10), 1453-1461. doi:10.1002/cncr.28592. Lewin, J., Farley-Loftus, R., & Pomeranz, M. K. (2011). Erythema multiforme-like drug reaction to sorafenib. Journal of Drugs in Dermatology, 10 (12), 1462-1463. Lewis, M., & Jordan, R. (2012). Oral medicine: A colour handbook (2nd ed.). London, UK: Thieme/Manson. Lezot, F., Chesneau, J., Battaglia, S., Brion, R., Castaneda, B., Farges, J. C., Heymann, D., & Redini, F. (2014). Preclinical evidence of potential craniofacial adverse effect of zoledronic acid in pediatric patients with bone malignancies. Bone, 68, 146-152. doi:10.1016/j. bone.2014.08.018. Lodi, G., Franchini, R., Warnakulasuriya, S., Varoni, E. M., Sardella, A., Kerr, A. R., … Worthington, H. V. (2016). Interventions for treating oral leukoplakia to prevent oral cancer. Cochrane Database of Systematic Reviews, 2016 (7), CD001829. Lorenzo-Pouso, A. I., Lafuente-Ibáñez de Mendoza, I., Pérez-Sayáns, M., Pérez-Jardón, A., Chamorro-Petronacci, C. M., Blanco-Carrión, A., & Aguirre-Urízar, J. M. (2022). Critical update, systematic review, and meta-analysis of oral erythroplakia as an oral potentially malignant disorder. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology , 51 (7), 585–593. https://doi.org/10.1111/jop.13304 Lyu, X., Zhao, C., Yan, Z. M., & Hua, H. (2016). Efficacy of nystatin for the treatment of oral candidiasis: A systematic review and meta- analysis. Journal of Drug Design, Development and Therapy, 10, 1161-1171. doi:10.2147/DDDT.S100795. Massot, A., & Gimenez-Arnau, A. (2014). Cutaneous adverse drug reaction type erythema multiforme major induced by eslicarbazepine. Journal of Pharmacology and Pharmacotherapeutics, 5 (4), 271-274. doi:10.4103/0976-500X.142456. Mayo Clinic. (2013). Leukoplakia: Complications. Retrieved from http://www.mayoclinic.org/ diseases- conditions/leukoplakia/basics/complications/con-20023802 McParland, H., & Warnakulasuriya, S. (2012). Oral lichenoid contact lesions to mercury and dental amalgam – A review. Journal of Biomedicine and Biotechnology, 2012, 589569. doi:10.1155/2012/589569. Miranda-Rius, J., Brunet-Llobet, L., Lahor-Soler, E., & Farré, M. (2015). Salivary secretory disorders, inducing drugs, and clinical management. International Journal of Medical Sciences, 12 (10), 811-824. doi:10.7150/ijms.12912 Mohan, R. P., Rastogi, K., Bhushan, R., & Verma, S. (2013). Phenytoin-induced gingival enlargement: A dental awakening for patients with epilepsy. BMJ Case Reports, 2013 . doi:10.1136/bcr-2013-008679. Moosazadeh, M., Shafaroudi, A. M., Gorji, N. E., Barzegari, S., & Nasiri, P. (2021). Prevalence of oral lesions in patients with AIDS: a systematic review and meta-analysis. Evidence-based dentistry , 10.1038/s41432-021-0209-8. Advance online publication. https://doi.org/10.1038/ s41432-021-0209-8 Murai, O., Naruishi, K., Ogihara, S., Suwa, N., Kanazawa, S., Yaegashi, T., Takeda, Y., & Kunimatsu, K. (2011). Cathepsin B, D, and L regulation in cyclosporin A-mediated gingival hyperplasia of a patient with sarcoidosis. Clinical Laboratory, 57 (7-8), 535-541. Nair, P. A. (2015). Ciprofloxacin induced bullous fixed drug reaction: Three case reports. Journal of Family Medicine and Primary Care, 4 (2), 269-272. doi:10.4103/2249- 4863.154673. Napeñas, J. J., Kujan, O., Arduino, P. G., Sukumar, S., Galvin, S., Baričević, M., Costella, J., Czerninski, R., Peterson, D. E., & Lockhart, P. B. (2015). World Workshop on Oral Medicine VI: Controversies regarding dental management of medically complex patients: assessment of current recommendations. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology, 120 (2):207-26. National Institutes of Health. (1989). Oral complications of cancer therapies: Diagnosis, prevention, and treatment – National Institutes of Health Consensus Development Conference Statement. NIH Consensus Statement, 7(7), 1-11. Retrieved from https:// consensus.nih.gov/1989/1989oralcomplicationscancertherapy073html.htm National Institutes of Health, National Institute of Dental and Craniofacial Research. (2014). Dry mouth (xerostomia). Retrieved from https://www.nidcr.nih.gov/OralHealth/Topics/ DryMouth/ National Research Council, Subcommittee on Health Effects of Ingested Fluoride. (1993). Health effects of ingested fluoride. Washington, DC: National Academy of Sciences. Ohshima, T., Kojima, Y., Seneviratne, C. J., & Maeda, N. (2016). Therapeutic application of synbiotics, a fusion of probiotics and prebiotics, and biogenics as a new concept for oral candida infections: A mini review. Frontiers in Microbiology, 7, 10. doi:10.3389/ fmicb.2016.00010. Ongole, R., & Praveen, B. N. (2013). Diseases of salivary glands. In Textbook of oral medicine, oral diagnosis and oral radiology (2nd ed., Chapter 11, pp. 265-300). New Delhi, India: Elsevier. Otto, S., Pautke, C., Van den Wyngaert, T., Niepel, D., & Schiødt, M. (2018). Medication- related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases. Cancer Treatment Reviews, 69 :177-187.
Page 104
Book Code: DHFL2624
EliteLearning.com/Dental
Powered by FlippingBook